
Scottsdale Interventional Forum 2020 Virtual
PCI vs CABG in Left Main Disease: Why So Controversial
FEATURING
Gregg Stone
- November 4, 2020
- 17
Scottsdale Interventional Forum 2020 Virtual
Valve-in-Valve TAVR I: Predicting When the Coronaries Are at Risk
FEATURING
Mark Reisman
- November 4, 2020
- 2
Scottsdale Interventional Forum 2020 Virtual
Non-Surgical Treatment of Aortic Insufficiency: Is TAVR an Option?
FEATURING
John Lasala
- November 4, 2020
- 1
Scottsdale Interventional Forum 2020 Virtual
A Novel Approach to Limiting Operator Radiation Exposure
FEATURING
James Goldstein
- November 4, 2020
Scottsdale Interventional Forum
The Top 5 Coronary Trials of the Past 2018 Year
FEATURING
Manish Parikh
- June 12, 2019
Scottsdale Interventional Forum 2020 Virtual
Coronary Revascularization Pre-TAVR: Why, Who, and When
FEATURING
Robert Applegate
- November 6, 2020
- 1
Scottsdale Interventional Forum 2020 Virtual
Challenges Executing and Publishing Cardiogenic Shock Trials
FEATURING
Sunil Rao
- November 4, 2020
Scottsdale Interventional Forum 2020 Virtual
Why Is the Left Atrial Appendage Occlusion Underutilized?
FEATURING
John Lasala
- November 4, 2020
- 2
Scottsdale Interventional Forum 2020 Virtual
Transeptal Mitral Valve Replacement in Severe MAC
FEATURING
Ashish Pershad
- November 4, 2020